nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP19A1—semen—hepatitis B	0.0277	0.268	CbGeAlD
Raloxifene—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0198	0.0317	CcSEcCtD
Raloxifene—Tenderness—Telbivudine—hepatitis B	0.0175	0.028	CcSEcCtD
Raloxifene—Migraine—Telbivudine—hepatitis B	0.0109	0.0175	CcSEcCtD
Raloxifene—EBP—liver—hepatitis B	0.0106	0.102	CbGeAlD
Raloxifene—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.01	0.016	CcSEcCtD
Raloxifene—Vasodilation procedure—Lamivudine—hepatitis B	0.00981	0.0157	CcSEcCtD
Raloxifene—Vasodilation—Lamivudine—hepatitis B	0.00981	0.0157	CcSEcCtD
Raloxifene—Influenza—Telbivudine—hepatitis B	0.0096	0.0153	CcSEcCtD
Raloxifene—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00953	0.0152	CcSEcCtD
Raloxifene—Oedema peripheral—Entecavir—hepatitis B	0.00921	0.0147	CcSEcCtD
Raloxifene—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00905	0.0145	CcSEcCtD
Raloxifene—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00901	0.0144	CcSEcCtD
Raloxifene—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00896	0.0143	CcSEcCtD
Raloxifene—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00894	0.0143	CcSEcCtD
Raloxifene—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00782	0.0125	CcSEcCtD
Raloxifene—Hypoaesthesia—Telbivudine—hepatitis B	0.00764	0.0122	CcSEcCtD
Raloxifene—Pharyngitis—Telbivudine—hepatitis B	0.00762	0.0122	CcSEcCtD
Raloxifene—Connective tissue disorder—Telbivudine—hepatitis B	0.00755	0.0121	CcSEcCtD
Raloxifene—CYP2C8—blood plasma—hepatitis B	0.00724	0.07	CbGeAlD
Raloxifene—Gastroenteritis—Lamivudine—hepatitis B	0.00706	0.0113	CcSEcCtD
Raloxifene—Cough—Adefovir Dipivoxil—hepatitis B	0.00693	0.0111	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00688	0.011	CcSEcCtD
Raloxifene—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00676	0.0108	CcSEcCtD
Raloxifene—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00676	0.0108	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00671	0.0107	CcSEcCtD
Raloxifene—Infection—Entecavir—hepatitis B	0.0066	0.0106	CcSEcCtD
Raloxifene—Nervous system disorder—Entecavir—hepatitis B	0.00651	0.0104	CcSEcCtD
Raloxifene—CYP2B6—blood plasma—hepatitis B	0.00649	0.0628	CbGeAlD
Raloxifene—Skin disorder—Entecavir—hepatitis B	0.00645	0.0103	CcSEcCtD
Raloxifene—Muscle spasms—Telbivudine—hepatitis B	0.00643	0.0103	CcSEcCtD
Raloxifene—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00636	0.0102	CcSEcCtD
Raloxifene—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00635	0.0101	CcSEcCtD
Raloxifene—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00629	0.0101	CcSEcCtD
Raloxifene—Migraine—Lamivudine—hepatitis B	0.00616	0.00985	CcSEcCtD
Raloxifene—Insomnia—Entecavir—hepatitis B	0.00601	0.00961	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.0059	0.00944	CcSEcCtD
Raloxifene—Dyspepsia—Entecavir—hepatitis B	0.00585	0.00935	CcSEcCtD
Raloxifene—Cough—Telbivudine—hepatitis B	0.00583	0.00933	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Entecavir—hepatitis B	0.00573	0.00917	CcSEcCtD
Raloxifene—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0057	0.00912	CcSEcCtD
Raloxifene—Chest pain—Telbivudine—hepatitis B	0.00569	0.0091	CcSEcCtD
Raloxifene—Myalgia—Telbivudine—hepatitis B	0.00569	0.0091	CcSEcCtD
Raloxifene—Arthralgia—Telbivudine—hepatitis B	0.00569	0.0091	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00565	0.00904	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00563	0.00901	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00559	0.00895	CcSEcCtD
Raloxifene—Gastrointestinal pain—Entecavir—hepatitis B	0.00543	0.00869	CcSEcCtD
Raloxifene—Influenza—Lamivudine—hepatitis B	0.00541	0.00865	CcSEcCtD
Raloxifene—Nervous system disorder—Telbivudine—hepatitis B	0.00535	0.00856	CcSEcCtD
Raloxifene—Thrombocytopenia—Telbivudine—hepatitis B	0.00534	0.00854	CcSEcCtD
Raloxifene—Skin disorder—Telbivudine—hepatitis B	0.0053	0.00848	CcSEcCtD
Raloxifene—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0053	0.00847	CcSEcCtD
Raloxifene—Body temperature increased—Entecavir—hepatitis B	0.00525	0.0084	CcSEcCtD
Raloxifene—Abdominal pain—Entecavir—hepatitis B	0.00525	0.0084	CcSEcCtD
Raloxifene—Bronchitis—Lamivudine—hepatitis B	0.0052	0.00832	CcSEcCtD
Raloxifene—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00512	0.00819	CcSEcCtD
Raloxifene—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00512	0.00819	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00497	0.00795	CcSEcCtD
Raloxifene—Insomnia—Telbivudine—hepatitis B	0.00494	0.00789	CcSEcCtD
Raloxifene—CYP3A4—blood plasma—hepatitis B	0.0049	0.0474	CbGeAlD
Raloxifene—Depression—Lamivudine—hepatitis B	0.00481	0.00769	CcSEcCtD
Raloxifene—Dyspepsia—Telbivudine—hepatitis B	0.0048	0.00768	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00471	0.00753	CcSEcCtD
Raloxifene—ESR2—blood—hepatitis B	0.0047	0.0454	CbGeAlD
Raloxifene—Pain—Telbivudine—hepatitis B	0.00467	0.00746	CcSEcCtD
Raloxifene—Sweating—Lamivudine—hepatitis B	0.00462	0.00739	CcSEcCtD
Raloxifene—Diarrhoea—Entecavir—hepatitis B	0.00454	0.00727	CcSEcCtD
Raloxifene—Sinusitis—Lamivudine—hepatitis B	0.00452	0.00723	CcSEcCtD
Raloxifene—Gastrointestinal pain—Telbivudine—hepatitis B	0.00446	0.00714	CcSEcCtD
Raloxifene—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00443	0.00709	CcSEcCtD
Raloxifene—Dizziness—Entecavir—hepatitis B	0.00439	0.00702	CcSEcCtD
Raloxifene—Rhinitis—Lamivudine—hepatitis B	0.00434	0.00694	CcSEcCtD
Raloxifene—Body temperature increased—Telbivudine—hepatitis B	0.00431	0.0069	CcSEcCtD
Raloxifene—Abdominal pain—Telbivudine—hepatitis B	0.00431	0.0069	CcSEcCtD
Raloxifene—Hypoaesthesia—Lamivudine—hepatitis B	0.00431	0.00689	CcSEcCtD
Raloxifene—Pharyngitis—Lamivudine—hepatitis B	0.0043	0.00687	CcSEcCtD
Raloxifene—Connective tissue disorder—Lamivudine—hepatitis B	0.00425	0.0068	CcSEcCtD
Raloxifene—Vomiting—Entecavir—hepatitis B	0.00422	0.00675	CcSEcCtD
Raloxifene—Rash—Entecavir—hepatitis B	0.00419	0.0067	CcSEcCtD
Raloxifene—Dermatitis—Entecavir—hepatitis B	0.00418	0.00669	CcSEcCtD
Raloxifene—Headache—Entecavir—hepatitis B	0.00416	0.00665	CcSEcCtD
Raloxifene—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00412	0.00659	CcSEcCtD
Raloxifene—Rash—Adefovir Dipivoxil—hepatitis B	0.00409	0.00653	CcSEcCtD
Raloxifene—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00408	0.00653	CcSEcCtD
Raloxifene—Headache—Adefovir Dipivoxil—hepatitis B	0.00406	0.00649	CcSEcCtD
Raloxifene—Nausea—Entecavir—hepatitis B	0.00395	0.00631	CcSEcCtD
Raloxifene—Nausea—Adefovir Dipivoxil—hepatitis B	0.00385	0.00616	CcSEcCtD
Raloxifene—Diarrhoea—Telbivudine—hepatitis B	0.00373	0.00597	CcSEcCtD
Raloxifene—Flatulence—Lamivudine—hepatitis B	0.00371	0.00594	CcSEcCtD
Raloxifene—CYP19A1—blood—hepatitis B	0.0037	0.0358	CbGeAlD
Raloxifene—ESR2—liver—hepatitis B	0.00368	0.0355	CbGeAlD
Raloxifene—SIGMAR1—blood—hepatitis B	0.00364	0.0352	CbGeAlD
Raloxifene—HTR2B—blood—hepatitis B	0.00363	0.0351	CbGeAlD
Raloxifene—Muscle spasms—Lamivudine—hepatitis B	0.00362	0.00579	CcSEcCtD
Raloxifene—Dizziness—Telbivudine—hepatitis B	0.00361	0.00577	CcSEcCtD
Raloxifene—AOX1—liver—hepatitis B	0.00354	0.0342	CbGeAlD
Raloxifene—Vomiting—Telbivudine—hepatitis B	0.00347	0.00555	CcSEcCtD
Raloxifene—Rash—Telbivudine—hepatitis B	0.00344	0.0055	CcSEcCtD
Raloxifene—Dermatitis—Telbivudine—hepatitis B	0.00344	0.0055	CcSEcCtD
Raloxifene—Headache—Telbivudine—hepatitis B	0.00342	0.00547	CcSEcCtD
Raloxifene—Vertigo—Lamivudine—hepatitis B	0.00339	0.00541	CcSEcCtD
Raloxifene—Syncope—Lamivudine—hepatitis B	0.00338	0.0054	CcSEcCtD
Raloxifene—Loss of consciousness—Lamivudine—hepatitis B	0.00331	0.0053	CcSEcCtD
Raloxifene—Cough—Lamivudine—hepatitis B	0.00329	0.00526	CcSEcCtD
Raloxifene—Nausea—Telbivudine—hepatitis B	0.00324	0.00518	CcSEcCtD
Raloxifene—ESR1—blood—hepatitis B	0.00322	0.0311	CbGeAlD
Raloxifene—Arthralgia—Lamivudine—hepatitis B	0.00321	0.00513	CcSEcCtD
Raloxifene—Chest pain—Lamivudine—hepatitis B	0.00321	0.00513	CcSEcCtD
Raloxifene—Myalgia—Lamivudine—hepatitis B	0.00321	0.00513	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00319	0.00509	CcSEcCtD
Raloxifene—Infection—Lamivudine—hepatitis B	0.00305	0.00489	CcSEcCtD
Raloxifene—Shock—Lamivudine—hepatitis B	0.00303	0.00484	CcSEcCtD
Raloxifene—Nervous system disorder—Lamivudine—hepatitis B	0.00302	0.00482	CcSEcCtD
Raloxifene—Thrombocytopenia—Lamivudine—hepatitis B	0.00301	0.00481	CcSEcCtD
Raloxifene—Skin disorder—Lamivudine—hepatitis B	0.00299	0.00478	CcSEcCtD
Raloxifene—Hyperhidrosis—Lamivudine—hepatitis B	0.00297	0.00475	CcSEcCtD
Raloxifene—CYP19A1—liver—hepatitis B	0.0029	0.028	CbGeAlD
Raloxifene—SIGMAR1—liver—hepatitis B	0.00285	0.0275	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.0028	0.00448	CcSEcCtD
Raloxifene—Insomnia—Lamivudine—hepatitis B	0.00278	0.00445	CcSEcCtD
Raloxifene—Dyspepsia—Lamivudine—hepatitis B	0.00271	0.00433	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00265	0.00425	CcSEcCtD
Raloxifene—CYP2C8—blood—hepatitis B	0.00265	0.0256	CbGeAlD
Raloxifene—Pain—Lamivudine—hepatitis B	0.00263	0.00421	CcSEcCtD
Raloxifene—ESR1—liver—hepatitis B	0.00252	0.0243	CbGeAlD
Raloxifene—Gastrointestinal pain—Lamivudine—hepatitis B	0.00251	0.00402	CcSEcCtD
Raloxifene—Abdominal pain—Lamivudine—hepatitis B	0.00243	0.00389	CcSEcCtD
Raloxifene—Body temperature increased—Lamivudine—hepatitis B	0.00243	0.00389	CcSEcCtD
Raloxifene—CYP2B6—blood—hepatitis B	0.00238	0.023	CbGeAlD
Raloxifene—Diarrhoea—Lamivudine—hepatitis B	0.0021	0.00336	CcSEcCtD
Raloxifene—CYP2C8—liver—hepatitis B	0.00207	0.02	CbGeAlD
Raloxifene—Dizziness—Lamivudine—hepatitis B	0.00203	0.00325	CcSEcCtD
Raloxifene—Vomiting—Lamivudine—hepatitis B	0.00196	0.00313	CcSEcCtD
Raloxifene—Rash—Lamivudine—hepatitis B	0.00194	0.0031	CcSEcCtD
Raloxifene—Dermatitis—Lamivudine—hepatitis B	0.00194	0.0031	CcSEcCtD
Raloxifene—Headache—Lamivudine—hepatitis B	0.00193	0.00308	CcSEcCtD
Raloxifene—CYP2B6—liver—hepatitis B	0.00186	0.018	CbGeAlD
Raloxifene—Nausea—Lamivudine—hepatitis B	0.00183	0.00292	CcSEcCtD
Raloxifene—CYP3A4—blood—hepatitis B	0.0018	0.0174	CbGeAlD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.00172	0.00633	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00171	0.00632	CbGpPWpGaD
Raloxifene—CYP19A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00168	0.00618	CbGpPWpGaD
Raloxifene—CYP19A1—Biological oxidations—GGT2—hepatitis B	0.00163	0.00601	CbGpPWpGaD
Raloxifene—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00161	0.00594	CbGpPWpGaD
Raloxifene—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.00156	0.00576	CbGpPWpGaD
Raloxifene—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00155	0.00571	CbGpPWpGaD
Raloxifene—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00147	0.00543	CbGpPWpGaD
Raloxifene—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00145	0.00536	CbGpPWpGaD
Raloxifene—CYP3A4—liver—hepatitis B	0.0014	0.0136	CbGeAlD
Raloxifene—ESR1—Estrogen signaling pathway—NFKB1—hepatitis B	0.00139	0.00514	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00135	0.00497	CbGpPWpGaD
Raloxifene—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00131	0.00483	CbGpPWpGaD
Raloxifene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00125	0.0046	CbGpPWpGaD
Raloxifene—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00123	0.00454	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—NR0B2—hepatitis B	0.00123	0.00453	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00122	0.0045	CbGpPWpGaD
Raloxifene—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00119	0.0044	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL10—hepatitis B	0.00117	0.00431	CbGpPWpGaD
Raloxifene—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.00113	0.00415	CbGpPWpGaD
Raloxifene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00111	0.00408	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—AKR1B1—hepatitis B	0.00108	0.00397	CbGpPWpGaD
Raloxifene—ESR1—FOXM1 transcription factor network—CDKN2A—hepatitis B	0.00106	0.00391	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GGT2—hepatitis B	0.00105	0.00386	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.00104	0.00384	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00103	0.00381	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—HLA-A—hepatitis B	0.00103	0.0038	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—NOS2—hepatitis B	0.00103	0.00379	CbGpPWpGaD
Raloxifene—EBP—Metabolism—AKR1B1—hepatitis B	0.00101	0.00374	CbGpPWpGaD
Raloxifene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00101	0.00373	CbGpPWpGaD
Raloxifene—CYP19A1—Biological oxidations—CYP2A6—hepatitis B	0.000987	0.00364	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GGT2—hepatitis B	0.000973	0.00359	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000966	0.00356	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000931	0.00343	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000911	0.00336	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000886	0.00327	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000865	0.00319	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—HNF4A—hepatitis B	0.000852	0.00314	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000806	0.00297	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.0008	0.00295	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—IFNG—hepatitis B	0.000788	0.00291	CbGpPWpGaD
Raloxifene—CYP19A1—Biological oxidations—GGT1—hepatitis B	0.000771	0.00284	CbGpPWpGaD
Raloxifene—AOX1—Disease—SAG—hepatitis B	0.000742	0.00274	CbGpPWpGaD
Raloxifene—AOX1—Disease—APOBEC3G—hepatitis B	0.000742	0.00274	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000705	0.0026	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—IFNG—hepatitis B	0.000704	0.00259	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IFNG—hepatitis B	0.000688	0.00254	CbGpPWpGaD
Raloxifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.000683	0.00252	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000669	0.00247	CbGpPWpGaD
Raloxifene—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00066	0.00243	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000653	0.00241	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—CYP2A6—hepatitis B	0.000634	0.00234	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—IL2—hepatitis B	0.000625	0.00231	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000623	0.0023	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NR0B2—hepatitis B	0.00062	0.00228	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000616	0.00227	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL2—hepatitis B	0.000611	0.00225	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000598	0.0022	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NR0B2—hepatitis B	0.000592	0.00218	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.00059	0.00217	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CYP2A6—hepatitis B	0.000589	0.00217	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—NFKB1—hepatitis B	0.000586	0.00216	CbGpPWpGaD
Raloxifene—ESR1—LKB1 signaling events—TP53—hepatitis B	0.000579	0.00214	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—PTEN—hepatitis B	0.000575	0.00212	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKR1B1—hepatitis B	0.000562	0.00207	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000549	0.00203	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000542	0.002	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—NFKB1—hepatitis B	0.000541	0.002	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000541	0.002	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GGT2—hepatitis B	0.000539	0.00199	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000537	0.00198	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GOT2—hepatitis B	0.000533	0.00196	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000524	0.00193	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000513	0.00189	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000512	0.00189	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000511	0.00188	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000508	0.00187	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—F2—hepatitis B	0.000496	0.00183	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.000495	0.00183	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000494	0.00182	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.00049	0.00181	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000489	0.0018	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—TGFB1—hepatitis B	0.000488	0.0018	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000487	0.0018	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000477	0.00176	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000476	0.00175	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00047	0.00173	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000465	0.00171	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GGT1—hepatitis B	0.00046	0.0017	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GOT1—hepatitis B	0.00046	0.0017	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000447	0.00165	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000444	0.00164	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000429	0.00158	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000423	0.00156	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.00042	0.00155	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000419	0.00155	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000419	0.00155	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CXCL10—hepatitis B	0.000412	0.00152	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—IL6—hepatitis B	0.000412	0.00152	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—HNF4A—hepatitis B	0.00041	0.00151	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000395	0.00146	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—hepatitis B	0.000392	0.00145	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000383	0.00141	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CXCL10—hepatitis B	0.000376	0.00139	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000375	0.00138	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.00036	0.00133	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL6—hepatitis B	0.000359	0.00132	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000356	0.00131	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000355	0.00131	CbGpPWpGaD
Raloxifene—AOX1—Disease—GOT2—hepatitis B	0.000353	0.0013	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000349	0.00129	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000347	0.00128	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000345	0.00127	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000329	0.00121	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP2A6—hepatitis B	0.000327	0.0012	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CCR5—hepatitis B	0.00032	0.00118	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000319	0.00118	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RIT2—hepatitis B	0.000316	0.00117	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SAG—hepatitis B	0.000316	0.00117	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000311	0.00115	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—CDKN1A—hepatitis B	0.00031	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000309	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PTEN—hepatitis B	0.000309	0.00114	CbGpPWpGaD
Raloxifene—AOX1—Disease—GOT1—hepatitis B	0.000304	0.00112	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NR0B2—hepatitis B	0.000298	0.0011	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000296	0.00109	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GOT2—hepatitis B	0.000295	0.00109	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CCR5—hepatitis B	0.000292	0.00108	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKR1B1—hepatitis B	0.000291	0.00107	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SAG—hepatitis B	0.000289	0.00107	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RIT2—hepatitis B	0.000289	0.00107	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000288	0.00106	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GGT2—hepatitis B	0.000279	0.00103	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—F2—hepatitis B	0.000274	0.00101	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000264	0.000974	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000258	0.000952	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000258	0.00095	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000256	0.000945	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GGT1—hepatitis B	0.000255	0.00094	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GOT1—hepatitis B	0.000255	0.00094	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—F2—hepatitis B	0.00025	0.000923	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ALB—hepatitis B	0.000245	0.000902	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SAG—hepatitis B	0.000241	0.000887	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RIT2—hepatitis B	0.000241	0.000887	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000237	0.000874	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL10—hepatitis B	0.000233	0.000859	CbGpPWpGaD
Raloxifene—AOX1—Disease—CCR5—hepatitis B	0.000227	0.000838	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000225	0.000829	CbGpPWpGaD
Raloxifene—AOX1—Disease—HLA-A—hepatitis B	0.000221	0.000816	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000213	0.000787	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL10—hepatitis B	0.000213	0.000784	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000212	0.000782	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL10—hepatitis B	0.000211	0.00078	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—HNF4A—hepatitis B	0.000207	0.000762	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000199	0.000735	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—hepatitis B	0.000193	0.000712	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL10—hepatitis B	0.000193	0.000712	CbGpPWpGaD
Raloxifene—AOX1—Disease—NOS2—hepatitis B	0.000193	0.00071	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTEN—hepatitis B	0.000187	0.000688	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKR1B1—hepatitis B	0.000187	0.000688	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CCR5—hepatitis B	0.000181	0.000666	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GGT2—hepatitis B	0.000179	0.00066	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000176	0.000648	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000176	0.000648	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP2A6—hepatitis B	0.000169	0.000623	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CCR5—hepatitis B	0.000165	0.000608	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCR5—hepatitis B	0.000164	0.000605	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000161	0.000593	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKR1B1—hepatitis B	0.000158	0.000583	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000157	0.000581	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—F2—hepatitis B	0.000155	0.000571	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GOT2—hepatitis B	0.000153	0.000563	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GGT2—hepatitis B	0.000152	0.000559	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCR5—hepatitis B	0.00015	0.000552	CbGpPWpGaD
Raloxifene—AOX1—Disease—CD4—hepatitis B	0.000143	0.000526	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—F2—hepatitis B	0.000141	0.000521	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—F2—hepatitis B	0.000141	0.000519	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ALB—hepatitis B	0.000136	0.0005	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GGT1—hepatitis B	0.000132	0.000486	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GOT1—hepatitis B	0.000132	0.000486	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—F2—hepatitis B	0.000128	0.000474	CbGpPWpGaD
Raloxifene—AOX1—Disease—CTNNB1—hepatitis B	0.000127	0.000467	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL10—hepatitis B	0.000125	0.000461	CbGpPWpGaD
Raloxifene—AOX1—Disease—CDKN1A—hepatitis B	0.000124	0.000456	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTEN—hepatitis B	0.000124	0.000455	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.00012	0.000443	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL10—hepatitis B	0.000114	0.00042	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2A6—hepatitis B	0.000108	0.0004	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2—hepatitis B	0.000104	0.000385	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTEN—hepatitis B	0.000103	0.000381	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFB1—hepatitis B	0.000102	0.000378	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GOT2—hepatitis B	9.81e-05	0.000362	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR5—hepatitis B	9.69e-05	0.000357	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2—hepatitis B	9.52e-05	0.000351	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL10—hepatitis B	9.5e-05	0.00035	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2—hepatitis B	9.48e-05	0.000349	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2A6—hepatitis B	9.18e-05	0.000339	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR5—hepatitis B	8.84e-05	0.000326	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2—hepatitis B	8.65e-05	0.000319	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	8.56e-05	0.000316	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKR1B1—hepatitis B	8.48e-05	0.000313	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GGT1—hepatitis B	8.47e-05	0.000312	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GOT1—hepatitis B	8.47e-05	0.000312	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—F2—hepatitis B	8.31e-05	0.000306	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GOT2—hepatitis B	8.3e-05	0.000306	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GGT2—hepatitis B	8.13e-05	0.0003	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—hepatitis B	7.72e-05	0.000285	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—F2—hepatitis B	7.59e-05	0.00028	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR5—hepatitis B	7.37e-05	0.000272	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GGT1—hepatitis B	7.17e-05	0.000264	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GOT1—hepatitis B	7.17e-05	0.000264	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—hepatitis B	7.01e-05	0.000259	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.53e-05	0.000241	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—F2—hepatitis B	6.32e-05	0.000233	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2—hepatitis B	5.6e-05	0.000206	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—hepatitis B	5.57e-05	0.000205	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CTNNB1—hepatitis B	5.4e-05	0.000199	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTEN—hepatitis B	5.35e-05	0.000197	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDKN1A—hepatitis B	5.28e-05	0.000195	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTEN—hepatitis B	5.27e-05	0.000194	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NFKB1—hepatitis B	5.24e-05	0.000193	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2—hepatitis B	5.11e-05	0.000188	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—hepatitis B	5.08e-05	0.000187	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CTNNB1—hepatitis B	4.93e-05	0.000182	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2A6—hepatitis B	4.93e-05	0.000182	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN1A—hepatitis B	4.82e-05	0.000178	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTEN—hepatitis B	4.81e-05	0.000177	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NFKB1—hepatitis B	4.78e-05	0.000176	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—hepatitis B	4.5e-05	0.000166	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GOT2—hepatitis B	4.46e-05	0.000164	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—hepatitis B	4.37e-05	0.000161	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2—hepatitis B	4.26e-05	0.000157	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CTNNB1—hepatitis B	4.11e-05	0.000151	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN1A—hepatitis B	4.01e-05	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTEN—hepatitis B	4e-05	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NFKB1—hepatitis B	3.99e-05	0.000147	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—hepatitis B	3.99e-05	0.000147	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GGT1—hepatitis B	3.85e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GOT1—hepatitis B	3.85e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—hepatitis B	3.81e-05	0.000141	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—hepatitis B	3.59e-05	0.000133	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTEN—hepatitis B	3.44e-05	0.000127	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—hepatitis B	3.32e-05	0.000122	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—hepatitis B	3.29e-05	0.000121	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—hepatitis B	3.28e-05	0.000121	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—hepatitis B	3e-05	0.000111	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTEN—hepatitis B	2.91e-05	0.000107	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—hepatitis B	2.73e-05	0.000101	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—hepatitis B	2.5e-05	9.22e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—hepatitis B	2.05e-05	7.54e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTEN—hepatitis B	1.56e-05	5.76e-05	CbGpPWpGaD
